Skip to Content
Merck
  • 2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitors.

2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitors.

Bioorganic & medicinal chemistry letters (2011-04-05)
Chaoyang Dai, Dansu Li, Janeta Popovici-Muller, Lianyun Zhao, Vinay M Girijavallabhan, Kristin E Rosner, Brian J Lavey, Razia Rizvi, Bandarpalle B Shankar, Michael K C Wong, Zhuyan Guo, Peter Orth, Corey O Strickland, Jing Sun, Xiaoda Niu, Shiying Chen, Joseph A Kozlowski, Daniel J Lundell, John J Piwinski, Neng-Yang Shih, M Arshad Siddiqui
ABSTRACT

TNF-α converting enzyme (TACE) inhibitors are promising agents to treat inflammatory disorders and cancer. We have investigated novel tartrate diamide TACE inhibitors where the tartrate core binds to zinc in a unique tridentate fashion. Incorporating (R)-2-(2-N-alkylaminothiazol-4-yl)pyrrolidines into the left hand side amide of the tartrate scaffold led to the discovery of potent and selective TACE inhibitors, some of which exhibited good rat oral bioavailability.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Cyclopropylboronic acid